Pine Haven Investment Counsel’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.52M Buy
17,973
+21
+0.1% +$4.52K 3.04% 6
2026
Q1
$3.9M Sell
17,952
-10
-0.1% -$2.22K 2.87% 6
2025
Q4
$4.1M Buy
17,962
+120
+0.7% +$27.3K 2.92% 7
2025
Q3
$4.13M Sell
17,842
-135
-0.8% -$27.5K 2.98% 5
2025
Q2
$3.34M Sell
17,977
-235
-1% -$43.7K 2.62% 7
2025
Q1
$3.82M Sell
18,212
-135
-0.7% -$26.2K 3.2% 6
2024
Q4
$3.26M Buy
18,347
+245
+1% +$45K 2.68% 6
2024
Q3
$3.57M Buy
18,102
+52
+0.3% +$9.71K 2.89% 6
2024
Q2
$3.1M Buy
18,050
+2
+0% +$331 2.66% 7
2024
Q1
$3.29M Sell
18,048
-60
-0.3% -$10.3K 2.89% 6
2023
Q4
$2.81M Sell
18,108
-10
-0.1% -$1.46K 2.62% 7
2023
Q3
$2.7M Sell
18,118
-422
-2% -$62K 2.8% 6
2023
Q2
$2.5M Sell
18,540
-63
-0.3% -$9.24K 2.49% 7
2023
Q1
$2.96M Sell
18,603
-185
-1% -$28.3K 3.11% 5
2022
Q4
$3.04M Buy
18,788
+140
+0.8% +$21.5K 3.34% 6
2022
Q3
$2.5M Sell
18,648
-54
-0.3% -$7.75K 3.05% 7
2022
Q2
$2.86M Sell
18,702
-60
-0.3% -$9.17K 3.35% 5
2022
Q1
$3.04M Sell
18,762
-44
-0.2% -$6.39K 2.98% 7
2021
Q4
$2.55M Buy
+18,806
New +$2.22M 2.37% 9

Other funds holding ABBV

Pine Haven Investment Counsel's ABBV Position: Q2 2026 in Review

Pine Haven Investment Counsel increased its AbbVie (ABBV) stake by 0.12% in Q2 2026, buying an estimated $4.52K and bringing the position to 17,973 shares worth $4.52M. The position accounts for 3.04% of the portfolio, ranked #6.

Pine Haven Investment Counsel first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pine Haven Investment Counsel held 17,973 shares of AbbVie worth $4.52M as of Q2 2026.
  • Pine Haven Investment Counsel bought 21 AbbVie shares in Q2 2026, an estimated $4.52K.
  • AbbVie made up 3.04% of Pine Haven Investment Counsel's portfolio in Q2 2026, its #6 holding.
  • Pine Haven Investment Counsel first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pine Haven Investment Counsel's 13F filing for Q2 2026, filed 8 Jul 2026.